Pre-Implant. Demographics Height:* in cm ST = Weight:* lbs kgs ST = Blood type:*

Size: px
Start display at page:

Download "Pre-Implant. Demographics Height:* in cm ST = Weight:* lbs kgs ST = Blood type:*"

Transcription

1 Pre-Implant Demographics Height:* in cm ST = Weight:* lbs kgs ST = Blood type:* Medical Support Status Current Device Strategy at time of implant:* Enter List Date:* mm/dd/yyyy ST= Concerns / Contraindications Overall Status: Is condition present? Patient (family) does not want transplant* YES NO Musculoskeletal limitation to ambulation (includes skeletal myopathy)* YES NO Limitation for transplant listing? * YES NO Contraindication to immunosuppression* YES NO Allosensitization * YES NO Frailty* YES NO Chronic renal disease* YES NO Cardiothoracic issues: Frequent ICD shocks* YES NO Pulmonary disease* YES NO Pulmonary hypertension* YES NO Recent pulmonary embolus* YES NO History of atrial arrhythmia * YES NO Unfavorable mediastinal anatomy (This includes sternotomies, sternal resection, radiation, flail chest, etc)* YES NO Enter # of Sternotomies:* 1

2 Thoracic aortic disease* YES NO Tracheostomy* YES NO Plastic Bronchitis* YES NO Nutritional/GI/Genetics: Large BMI * YES NO Severe Diabetes* YES NO Malnutrition/cachexia* YES NO History of GI ulcers* YES NO History of hepatitis* YES NO Liver dysfunction* YES NO Anasarca* YES NO Protein losing enteropathy* YES NO Genetic Syndrome* YES NO Genetic syndrome* Other:* Vascular issues: Heparin-induced thrombocytopenia* YES NO Chronic coagulopathy* YES NO Major stroke* YES NO Other cerebrovascular disease* YES NO Peripheral vascular disease* YES NO 2

3 Oncology/infection issues: History of solid organ cancer* YES NO History of lymphoma, leukemia* YES NO History of bone marrow transplant (BMT)* YES NO History HIV* YES NO Chronic infectious concerns* YES NO Psychosocial issues (If patient is <10 years old at time of implant then these answers pertain to the primary guardian).: Limited congition/understanding* YES NO Limited social support* YES NO Repeated non-compliance* YES NO History of illicit drug use* YES NO History of alcohol abuse* YES NO Narcotic dependence* YES NO History of smoking* YES NO Currently smoking * YES NO Severe depression* YES NO Other major psychiatric diagnosis* YES NO Neurological/developmental abnormalities* YES NO Other co-morbidity* YES NO Time since first cardiac diagnosis: Was the patient treated for heart failure prior to admission?:* If yes, number of heart failure YES NO UNK 3

4 hospitalizations in the last year:* Primary cardiac diagnosis:* Dilated Cardiomyopathy Restrictive Cardiomyopathy Congenital Heart Disease: Single Ventricular Other:* Previous cardiac operation (check all that apply):* None CABG Aneuryomectomy (DOR) Aortic Valve replacement / repair Mitral valve replacement / repair Triscuspid replacement /repair Congenital card surg LVAD RVAD TAH Previous heart transplant Previous ECMO Other, specify (INCLUDE ONLY OPERATIONS ACTUALLY PERFORMED ON HEART OR GREAT VESSELS) If congenital cardiac surg then check all that apply:* Congenitally Corrected Transposition Repair (double switch) Congenitally Corrected Transposition Repair (classic) PA Banding TOF/DORV/RVOTO Repair Ebstein's Anomaly Repair VSD Repair Norwood Stage I Glenn Procedure Fontan Procedure d- Transposition of the Great Vessels Repair - arterial switch operation d- Transposition of the Great Vessels Repair - atrial switch (Senning/Mustard) Truncus Arteriosus Repair Complete AV Septal Defect Repair Hybrid Repair Other, specify Admitting Diagnosis or Planned Implant:* Non-Cardiac medical problem:* GI (nausea, vomiting, diarrhea) Respiratory (SOB, wheezing, respiratory failure) FTT Lethargy Other, specify Clinical Events and Interventions this hospitalization (Pre-implant):* CABG Aortic Valve replacement/repair Mitral Valve replacement/repair Congenital cardiac surg Other surgical procedures IABP ECMO 4

5 If congenital cardiac surg then check all that apply:* Other surgical procedure:* Infection type* Location of infection:* Other, specify:* LVAD RVAD TAH Dialysis Ultrafiltration Feeding tube Intubation Major MI Major Infections/Positive blood cultures None Escalation to CPAP Arrythmia Previous ECMO Previous heart transplant Treatment of Rejection Peritoneal Drain Non-cardiac procedure Congenitally Corrected Transposition Repair (double switch) Congenitally Corrected Transposition Repair (classic) PA Banding TOF/DORV/RVOTO Repair Ebstein's Anomaly Repair VSD Repair Norwood Stage I Glenn Procedure Fontan Procedure d- Transposition of the Great Vessels Repair - arterial switch operation d- Transposition of the Great Vessels Repair - atrial switch (Senning/Mustard) Truncus Arteriosus Repair Complete AV Septal Defect Repair Hybrid Repair Other, specify Best Functional Capacity within 24 hours of implant Paralyzed:* YES NO Intubated:* YES NO Ambulating:* YES NO Primary Nutrition:* IV therapy at implant* YES NO UNK IV inotrope therapy agents (check all that apply):* Dobutamine Dopamine Milrinone Levosimendan Epinephrine Norepinephrine 5

6 Isoproterenol Vasopressin Nitroprusside Fenoldopam Neseritide Other, specify Loop diuretics:* YES NO UNK If yes, enter dosage:* mg/day ST= If dose is entered, then check type of loop diuretic (check all that apply):* Furosemide Torsemide Bumetanide Other PEDIMACS Patient Profile at time of implant decision:* 1 "Critical cardiogenic shock" describes a patient who is "crashing and burning", in which a patient has life-threatening hypotension and rapidly escalating inotropic pressor support, with critical organ hypo perfusion often confirmed by worsening acidosis and lactate levels. This patient can have modifier A or TCS (see 'Modifiers' below) 2 "Progressive decline" describes a patient who has been demonstrated "dependent" on inotropic support but nonetheless shows signs of continuing deterioration in nutrition, renal function, hepatic function, respiratory function, fluid retention, nutrition, tachyarrhythmia, or other major status indicator. Patient profile 2 can also describe a patient with refractory volume overload, perhaps with evidence of impaired perfusion, in whom inotropic infusions cannot be maintained due to tachyarrhythmia, clinical ischemia, or other intolerance. This patient can have modifiers A or TCS. 3 "Stable but inotrope dependent" describes a patient who is clinically stable on mild-moderate doses of intravenous inotropes (or has a temporary circulatory support device) after repeated documentation of failure to wean without symptomatic hypotension, worsening symptoms, or progressive organ dysfunction (usually renal). It is critical to monitor nutrition, renal function, fluid balance, and overall status carefully in order to distinguish between a patient who is truly stable at Patient Profile 3 and a patient who has unappreciated decline rendering them Patient Profile 2. This patient may be either at home or in the hospital. Patient Profile 2 can have modifier A, and if in the hospital with circulatory support can have modifier TCS. If patient is at home most of the time on outpatient inotropic infusion, this patient can have a modifier FF if he or she frequently returns to the hospital. 4 "Resting symptoms" describes a patient who is at home on oral therapy but frequently has symptoms of congestion at rest or with ADL. He or she may have orthopnea, shortness of breath during ADL such as dressing or bathing, gastrointestinal symptoms (abdominal discomfort, nausea, poor appetite), disabling ascites or severe peripheral edema (extremity or facial). This patient should be carefully considered for more intensive management and surveillance programs, by which some may be recognized to have poor compliance that would compromise outcomes with any therapy. This patient can have modifiers A and/or FF. 5 "Exertion Intolerant" describes a patient who is comfortable at rest but unable to engage in any activity, living predominantly within the house or housebound. This patient has no congestive symptoms, but may have chronically elevated volume status, frequently with renal dysfunction, and may be characterized as exercise intolerant. This patient can have modifiers A and/or FF. 6 "Exertion Limited" also describes a patient who is comfortable at rest without evidence of fluid overload, but who is able to do some mild activity. Activities of daily living are comfortable and minor activities outside the home such as visiting friends or going to a restaurant can be performed, but fatigue results within a few minutes or any meaningful physical exertion. This patient has occasional episodes of worsening symptoms and is likely to have had a hospitalization for heart failure within the past year. This patient can have modifiers A and/or FF. 7 "Advanced NYHA Class 3" or "Ross Class III" describes a patient who is clinically stable with a reasonable level of comfortable activity, despite history of previous decompensation that is not recent. This patient is usually able to walk more than a block. Any decompensation requiring intravenous diuretics or hospitalization within the previous month should make this person a Patient Profile 6 or lower. This patient may have a modifier A only. Modifier 'A' - Arrythmia* YES NO UNK Modifier 'TCS' - Temporary Circulatory Support* YES NO UNK Modifier 'FF' - Frequent Flyer* YES NO UNK Primary Reason: Clinical manifestation 6

7 of heart failure prompting VAD insertion according to the implanting physician (select primary reason):* Check all that apply:* Secondary Reason(s): Clinical manifestations of heart failure prompting VAD insertion according to the implanting physician (check all other reasons that apply that are not the primary reason selected above):* Emesis or inadequate calories (<70% prescribed) requiring enteral feeding tube placement Recurrent emesis with adequate caloric intake despite feeding tube placement Inadequate caloric intake (with or without emesis) despite feeding tube placement Requiring parenteral (IV) nutrition Decline in renal function Decline in hepatic function Decline in respiratory function Refractory fluid retention/volume overload Decline in cardiac output (by exam, mixed venous saturation, or cath) prior to onset of worsening acidosis/lactate Decline in nutrition/feeding intolerance, if so check all that apply Incessant severe sinus tachycardia Worsening tachyarrhythmia Other, please specify Not reported Check all that apply:* Emesis or inadequate calories (<70% prescribed) requiring enteral feeding tube placement Recurrent emesis with adequate caloric intake despite feeding tube placement Inadequate caloric intake (with or without emesis) despite feeding tube placement Requiring parenteral (IV) nutrition Hemodynamics (Prior to implant - closest to implant but not in OR) Peripheral edema* YES NO UNK Ascites:* YES NO UNK ECG rhythm (cardiac rhythm):* Echo Findings - closest to implant Systemic AV Valve Regurgitation:* Right AV Valve Regurgitation (Pulmonary):* Aortic regurgitation:* Systemic Ventricle Ejection Fraction:* LVEDD:* cm ST= RV Function:* Was there thrombus identified by ECHO?* If yes, please check all that apply:* YES NO RA - Right Atrium RV - Right Ventricle LA - Left Atrium SVC - Superior Vena Cava IVC - Inferior Vena Cava 7

8 Invasive Hemodynamics - closest to implant (within one month of implant) Date of Measurement:* mm/dd/yyyy ST= Heart ST= rate:* beats per min Pulmonary artery systolic pressure:* mm Hg ST= Pulmonary artery diastolic pressure:* mm Hg ST= Mean RA Pressure:* mm Hg ST= PVRI:* wood units ST= Mean Pulmonary artery wedge mm Hg ST= pressure OR LVEDP:* Cardiac Index:* L/min/m 2 ST= Current ICD device in place:* YES NO UNK Cardiac Resynchronization Therapy (CRT):* YES NO UNK Laboratory - closest to implant (or appropriate guidance) Sodium:* mmol/l ST= Potassium:* meq/l ST= Blood urea nitrogen:* mg/dl ST= Creatinine:* mg/dl ST= SGPT/ALT (alanine u/l ST= aminotransferase/alt):* SGOT/AST (aspartate u/l ST= aminotransferase/ast):* LDH:* U/L ST= Total bilirubin:* mg/dl ST= Bilirubin direct:* mg/dl ST= Bilirubin indirect:* mg/dl ST= Albumin:* g/dl ST= Pre-albumin:* mg/dl ST= Total Cholesterol:* mg/dl ST= If value is outside given range please see 'status' drop down field Brain natriuretic peptide BNP:* pg/ml ST= If value is outside given range please see 'status' drop down field NT pro brain natriuretic peptide pg/ml ST= Pro-BNP:* White blood cell count:* K/uL ST= Reticulocyte count:* % ST= Hemoglobin:* g/dl ST= Platelets:* K/uL ST= INR:* international units ST= Uric Acid: * mg/dl ST= Lymphocyte Count: * % ST= Does the patient have a history YES NO UNK 8

9 of lupus anticoagulant?:* Medical Condition NYHA class:* Ross Classification of Congestive Heart Failure (patient < 2 yrs of age):* Class I: No limitation of physical activity; physical activity does not cause fatigue, palpitation or shortness of breath. Class II: Slight limitation of physical activity; comfortable at rest, but ordinary physical activity results in fatigue, palpitations or shortness of breath. Class III: Marked limitation of physical activity; comfortable at rest, but less than ordinary activity causes fatigue, palpitation or shortness of breath. Class IV: Unable to carry on minimal physical activity without discomfort; symptoms may be present at rest. Ross class II:* Mild tachypnea with feeds in infant Mild diaphoresis with feeds in infant Dyspnea on exercise in older children Ross class III:* Marked tachypnea with exertion or with feeding Marked diaphoresis with exertion or with feeding Ross class IV:* Tachypnea Retractions Grunting Diaphoresis Exercise Function - closest to implant (or appropriate guidance) 6 minute walk:* feet ST= Gait Speed (1st 15 foot walk):* seconds ST= Peak VO2 Max: Maximum volume ml/kg/min ST= of oxygen the body can consume during exercise:* R Value at peak:* % ST= PEDSQOL: Child Did the child complete a form?:* YES NO UNK Please enter the reason the PEDSQOL form was not completed* Administrative (check specific reason):* Please select the "Child" form* Too Sick Administrative ABOUT MY HEALTH AND ACTIVITIES (problems with...) 1. It is hard for me to walk more than one block:* 2. It is hard for me to run:* 3. It is hard for me to do sports activity or exercise:* 4. It is hard for me to lift something heavy:* 5. It is hard for me to take a bath or shower by myself:* 9

10 6. It is hard for me to do chores around the house:* 7. I hurt or ache:* 8. I have low energy:* ABOUT MY FEELINGS (problems with...) 1. I feel afraid or scared:* 2. I feel sad or blue:* 3. I feel angry:* 4. I have trouble sleeping:* 5. I worry about what will happen to me:* HOW I GET ALONG WITH OTHERS (problems with...) 1. I have trouble getting along with other teens:* 2. Other teens do not want to be my friend:* 3. Other teens tease me:* 4. I cannot do things that other teens my age can do:* 5. It is hard to keep up with my peers:* ABOUT SCHOOL (problems with...) 1. It is hard to pay attention in class:* 2. I forget things:* 3. I have trouble keeping up with my schoolwork:* 4. I miss school because of not feeling well:* 5. I miss school to go to the doctor or hospital:* PHYSICAL FUNCTIONING (problems with...) 1. It is hard for you to walk:* 2. It is hard for you to run:* 3. It is hard for you to play sports or exercise:* 4. It is hard for you to pick up big things:* 5. It is hard for you to take a bath or shower:* 6. It is hard for you to do chores (like pick up your toys):* 7. Do you have hurts or aches:* Where?:* 8. Do you ever feel to tired to play:* EMOTIONAL FUNCTIONING (problems with...) 1. Do you feel scared:* 2. Do you feel sad:* 3. Do you feel mad:* 4. Do you have trouble sleeping:* 5. Do you worry about what will happen to you:* 10

11 SOCIAL FUNCTIONING (problems with...) 1. Is it hard for you to get along with other kids:* 2. Do other kids say they do not want to play with you:* 3. Do other kids tease you:* 4. Can other kids do things that you cannot do:* 5. Is it hard for you to keep up when you play with other kids:* SCHOOL FUNCTIONING (problems with...) 1. Is it hard for you to pay attention in school:* 2. Do you forget things:* 3. Is it hard to keep up with schoolwork:* 4. Do you miss school because of not feeling good:* 5. Do you miss school because you have to go to the doctor or hospital:* PEDSQOL: Parent Did the parent complete a form?:* YES NO UNK Please enter the reason the PEDSQOL form was not completed* Administrative (check specific reason):* Please select the "Parent" form* Too Sick Administrative PHYSICAL FUNCTIONING (problems with...) 1. Walking more than one block:* 2. Running:* 3. Participating in sports activity or exercise:* 4. Lifting something heavy:* 5. Taking a bath or shower by him or herself:* 6. Doing chores, like picking up his or her toys:* 7. Having hurts or aches:* 8. Low energy level:* EMOTIONAL FUNCTIONING (problems with...) 1. Feeling afraid or scared:* 3. Feeling sad or blue:* 3. Feeling angry:* 4. Trouble sleeping:* 5. Worrying about what will happen to him or her:* SOCIAL FUNCTIONING (problems with...) 1. Getting along with other children:* 2. Other kids not wanting to be his or her friend:* 11

12 3. Getting teased by other children:* 4. Not able to do things that other children his or her age can do:* 5. Keeping up when playing with other children:* SCHOOL FUNCTIONING (problems with...) 1. Paying attention in class:* 2. Forgetting things:* 3. Keeping up with school activities:* 4. Missing school because of not feeling well:* 5. Missing school to go to the doctor or hospital:* 12

3 Month / 6 Month Follow-Up

3 Month / 6 Month Follow-Up 3 Month / 6 Month Follow-Up Select one of the following:* Follow-up date:* Facility Type:* State reason why you are unable to obtain follow-up information:* General Hemodynamics - during report interval

More information

1 Week Followup 5/27/2014. Nursing Home/Assisted Care Hospice Another hospital Rehabilitation Facility Unknown

1 Week Followup 5/27/2014. Nursing Home/Assisted Care Hospice Another hospital Rehabilitation Facility Unknown 1 Week Followup t Started Please answer all questions considering all time since the previous visit and current follow-up date. Print this Form Followup Status t Started Select one of the following Inpatient

More information

Inpatient Outpatient Other Facility Unable to obtain follow up information

Inpatient Outpatient Other Facility Unable to obtain follow up information version date: 12/10/2015 1 Month Followup Followup Status (1 Month Followup (+/ 7 days)) Select one of the following Inpatient Outpatient Other Facility Unable to obtain follow up information Follow up

More information

1 Week Followup - Intermacs

1 Week Followup - Intermacs version date: 9/27/2017 1 Week Followup - Intermacs Followup Status (1 Week Followup (+/- 3 days)) Select one of the following Inpatient Outpatient Other Facility Unable to obtain follow-up information

More information

1 Month Followup - Pedimacs

1 Month Followup - Pedimacs version date: 03/27/2018 1 Month Followup - Pedimacs Followup Status (1 Month Followup (+/- 7 days)) Select one of the following Inpatient Outpatient Other Facility Unable to obtain follow-up information

More information

Followup Status (1 Week Followup (+/- 3 days))

Followup Status (1 Week Followup (+/- 3 days)) 1 Week Followup - Status version date: 09/27/2018 Intermacs 1 Week Followup Followup Status (1 Week Followup (+/- 3 days)) Select one of the following Inpatient Outpatient Other Facility Unable to obtain

More information

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart

More information

PreImplant - Pedimacs

PreImplant - Pedimacs PreImplant - Status PreImplant - Pedimacs PreImplant Status Demographics Height Not Done in cm Weight Not Done lbs kg Blood Type O A B AB Medical Support Status Current Device Strategy at time of implant

More information

PreImplant - Pedimacs

PreImplant - Pedimacs version date: 12/19/2017 PreImplant - Pedimacs PreImplant Status Demographics Height ST= Not Done in cm Weight ST= Not Done lbs kg Blood Type O A B AB Medical Support Status Current Device Strategy at

More information

PreImplant. Demographics. Medical Support Status. Concerns / Contraindications. Height: in cm Unknown. Not Done. Weight: lbs kgs Unknown.

PreImplant. Demographics. Medical Support Status. Concerns / Contraindications. Height: in cm Unknown. Not Done. Weight: lbs kgs Unknown. PreImplant Demographics Height: in cm t Done Weight: lbs kgs t Done Blood Type: O A B AB Medical Support Status Current Device Strategy at time of implant: Enter List Date: Bridge to Recovery Rescue Therapy

More information

Medical Management of Acute Heart Failure

Medical Management of Acute Heart Failure Critical Care Medicine and Trauma Medical Management of Acute Heart Failure Mary O. Gray, MD, FAHA Associate Professor of Medicine University of California, San Francisco Staff Cardiologist and Training

More information

Policy Specific Section: May 16, 1984 April 9, 2014

Policy Specific Section: May 16, 1984 April 9, 2014 Medical Policy Heart Transplant Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Transplant Original Policy Date: Effective Date: May 16, 1984 April 9, 2014 Definitions

More information

Quality of Life in Pediatric VAD- How are we doing?

Quality of Life in Pediatric VAD- How are we doing? Quality of Life in Pediatric VAD- How are we doing? INTERMACS Eighth Annual Meeting May 5, Karen Uzark, PhD, CPNP University of Michigan Congenital Heart Center Definitions HEALTH = not only the absence

More information

DEMYSTIFYING VADs. Nicolle Choquette RN MN Athabasca University

DEMYSTIFYING VADs. Nicolle Choquette RN MN Athabasca University DEMYSTIFYING VADs Nicolle Choquette RN MN Athabasca University Objectives odefine o Heart Failure o VAD o o o o Post Operative Complications Acute Long Term Nursing Interventions What is Heart Failure?

More information

Heart Failure: Guideline-Directed Management and Therapy

Heart Failure: Guideline-Directed Management and Therapy Heart Failure: Guideline-Directed Management and Therapy Guideline-Directed Management and Therapy (GDMT) was developed by the American College of Cardiology and American Heart Association to define the

More information

Tips & tricks on how to treat an acute heart failure patient with low cardiac output and diuretic resistance

Tips & tricks on how to treat an acute heart failure patient with low cardiac output and diuretic resistance Tips & tricks on how to treat an acute heart failure patient with low cardiac output and diuretic resistance J. Parissis Attikon University Hospital, Athens, Greece Disclosures ALARM investigator received

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

Implantable Ventricular Assist Devices and Total Artificial Hearts. Policy Specific Section: June 13, 1997 March 29, 2013

Implantable Ventricular Assist Devices and Total Artificial Hearts. Policy Specific Section: June 13, 1997 March 29, 2013 Medical Policy Implantable Ventricular Assist Devices and Total Artificial Hearts Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective

More information

: 2014 INTERMACS 4.0 Launches June 2, 2014

: 2014 INTERMACS 4.0 Launches June 2, 2014 : 2014 INTERMACS 4.0 Launches June 2, 2014 David C. Naftel, PhD 1 June 2006 March 2014 UAB: DCC UNOS: WBDE 2 : 2006 What patients are receiving MCSDs? Do DT patients ever receive a transplant? What are

More information

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 Medical Treatment for acute Decompensated Heart Failure Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 2010 HFSA guidelines for ADHF 2009 focused update of the 2005 American College

More information

4a.i. 4a.ii. Form 12: Pre Transplant Status Report. Height and Weight. Status.

4a.i. 4a.ii. Form 12: Pre Transplant Status Report. Height and Weight. Status. PHTS - Form : Pre Transplant Report Page of 5 Patient Details Hidden Show Show/Hide Annotations Stickies: Toggle All Toggle Open Toggle Resolved Form : Pre Transplant Report Print this Form t Started Was

More information

Followup 5/27/2014. Nursing Home/Assisted Care Hospice Another hospital Rehabilitation Facility Unknown

Followup 5/27/2014. Nursing Home/Assisted Care Hospice Another hospital Rehabilitation Facility Unknown 3 Month Followup t Started Please answer all questions considering all time since the previous visit and current follow-up date. Print this Form Followup Status t Started Select one of the following Inpatient

More information

Heart Failure Medical and Surgical Treatment

Heart Failure Medical and Surgical Treatment Heart Failure Medical and Surgical Treatment Daniel S. Yip, M.D. Medical Director, Heart Failure and Transplantation Mayo Clinic Second Annual Lakeland Regional Health Cardiovascular Symposium February

More information

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept (MBBS)(SBMD) Introduction Epidemiology Pathophysiology diastolic/systolic Risk factors Signs and symptoms Classification of HF

More information

AllinaHealthSystem 1

AllinaHealthSystem 1 : Definition End-organ hypoperfusion secondary to cardiac failure Venoarterial ECMO: Patient Selection Michael A. Samara, MD FACC Advanced Heart Failure, Cardiac Transplant & Mechanical Circulatory Support

More information

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize The Role of Mechanical Circulatory Support in Cardiogenic Shock: Presented by Nancy Scroggins ACNP, CNS-CC CV Surgery ACNP Bayshore Medical Center The Role of Mechanical Circulatory Support in Cardiogenic

More information

Tri-City Cardiology Consultants FIFTH ANNUAL SYMPOSIUM

Tri-City Cardiology Consultants FIFTH ANNUAL SYMPOSIUM Tri-City Cardiology Consultants FIFTH ANNUAL SYMPOSIUM Faculty Disclosure Banner Baywood Medical Center -Chief of Staff FIFTH ANNUAL SYMPOSIUM NYHA class III-IV symptoms Clinical signs of fluid retention

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,

More information

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover

More information

Management of acute decompensated heart failure and cardiogenic shock. Arintaya Phrommintikul Department of Medicine CMU

Management of acute decompensated heart failure and cardiogenic shock. Arintaya Phrommintikul Department of Medicine CMU Management of acute decompensated heart failure and cardiogenic shock Arintaya Phrommintikul Department of Medicine CMU Acute heart failure: spectrum Case 64 y/o M with Hx of non-ischemic DCM (LVEF=25-30%)

More information

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist Dr Stephen Pettit, Consultant Cardiologist Cardiogenic shock Management of Cardiogenic Shock Outline Definition, INTERMACS classification Medical management of cardiogenic shock PA catheters and haemodynamic

More information

Heart Disorders. Cardiovascular Disorders (Part B-1) Module 5 -Chapter 8. Overview Heart Disorders Vascular Disorders

Heart Disorders. Cardiovascular Disorders (Part B-1) Module 5 -Chapter 8. Overview Heart Disorders Vascular Disorders Cardiovascular Disorders (Part B-1) Module 5 -Chapter 8 Overview Heart Disorders Vascular Disorders Susie Turner, MD 1/7/13 Heart Disorders Coronary Artery Disease Cardiac Arrhythmias Congestive Heart

More information

Management Strategies for Advanced Heart Failure

Management Strategies for Advanced Heart Failure Management Strategies for Advanced Heart Failure Mary Norine Walsh, MD, FACC Medical Director, HF and Cardiac Transplantation St Vincent Heart Indianapolis, IN USA President American College of Cardiology

More information

Percutaneous Mechanical Circulatory Support Devices

Percutaneous Mechanical Circulatory Support Devices Percutaneous Mechanical Circulatory Support Devices Daniel Vazquez RN, RCIS Miami Cardiac & Vascular Institute FINANCIAL DISCLOSURES none CASE STUDY CASE STUDY 52 year old gentlemen Complaining of dyspnea

More information

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Heart Failure Heart Failure Introduction and History AHA 2015 Statistics About 6 million Americans 870,000 new cases each year 1 in 9 deaths related to HF Almost 1 million hospitalizations each year (cost

More information

Form 8: Post Transplant Annual Followup

Form 8: Post Transplant Annual Followup Page 1 of 7 Show trials/registries Patient Details Hidden Show Show/Hide Annotations Stickies: Toggle All Toggle Open Toggle Resolved Form 8: Post Transplant Annual Followup Print this Form t Started 1

More information

ACUTE HEART FAILURE. Julie Gorchynski MD, MSc, FACEP, FAAEM. Department of Emergency Medicine Emergency Residency Program UTHSC, San Antonio TCEP 2014

ACUTE HEART FAILURE. Julie Gorchynski MD, MSc, FACEP, FAAEM. Department of Emergency Medicine Emergency Residency Program UTHSC, San Antonio TCEP 2014 ACUTE HEART FAILURE Julie Gorchynski MD, MSc, FACEP, FAAEM Department of Emergency Medicine Emergency Residency Program UTHSC, San Antonio TCEP 2014 No disclosures Objectives Overview Cases Current Therapy

More information

Clinical Case. Female, 62 years January 2016

Clinical Case. Female, 62 years January 2016 Clinical Case Female, 62 years January 2016 Dr. Ramón Corbalán H. Facultad de Medicina División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile Clinical Hx Background: Ostheoartritis

More information

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations

More information

DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE. Jules B. Puschett, M.D.

DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE. Jules B. Puschett, M.D. DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE Jules B. Puschett, M.D. Diuretic Resistance A clinical circumstance in which patients do not respond to a combination of salt restriction and even large

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

Pre-discussion questions

Pre-discussion questions Amanda Bartlett, PA-C Dustin Bartlett, PA-C Andrea Applegate, PA-C Leslie Yearta Brown, NP CHF Round Table Discussion Objectives ANDREA- Discuss the definition and different categories of CHF DUSTIN- Define

More information

Anatomy & Physiology

Anatomy & Physiology 1 Anatomy & Physiology Heart is divided into four chambers, two atrias & two ventricles. Atrioventricular valves (tricuspid & mitral) separate the atria from ventricles. they open & close to control flow

More information

2/28/2017. Adult Heart Transplants Donor and Recipient Characteristics UNOS, Retransplant VCM. Other /2015 (N = 24,474)

2/28/2017. Adult Heart Transplants Donor and Recipient Characteristics UNOS, Retransplant VCM. Other /2015 (N = 24,474) 1 46% 2% 3% 4% 0% 2% 2% CHD HCM ICM NICM RCM 49% 3% 3% 3% 1% 3% 3% Retransplant VCM 42% Other 35% 1/1982 6/2015 1/2009 6/2015 2016 JHLT. 2016 Oct; 35(10): 1149-1205 UNOS, 2017 Adult Heart Transplants Donor

More information

Form 8: Post Transplant Annual Followup

Form 8: Post Transplant Annual Followup Page 1 of 8 Patient Details Hidden Show Show/Hide Annotations Stickies: Toggle All Toggle Open Toggle Resolved Form 8: Post Transplant Annual Followup Toggle Question Year/Info Print this Form t Started

More information

Ramani GV et al. Mayo Clin Proc 2010;85:180-95

Ramani GV et al. Mayo Clin Proc 2010;85:180-95 THERAPIES FOR ADVANCED HEART FAILURE: WHEN TO REFER Navin Rajagopalan, MD Assistant Professor of Medicine University of Kentucky Director, Congestive Heart Failure Medical Director of Cardiac Transplantation

More information

The ACC Heart Failure Guidelines

The ACC Heart Failure Guidelines The ACC Heart Failure Guidelines Fakhr Alayoubi, Msc,R Ph President of SCCP Cardiology Clinical Pharmacist Assistant Professor At King Saud University King Khalid University Hospital Riyadh-KSA 2017 ACC/AHA/HFSA

More information

CLASIFICATION OF ACUTE HEART FAILURE

CLASIFICATION OF ACUTE HEART FAILURE CLASIFICATION OF ACUTE HEART FAILURE CLINICAL STATUS HR SBP mmhg CI L/min/m 2 PCWP mmhg Congestion Killip/Forrester Diuresis Hupoperfusion End-organ hypoperfusion I. Acute decompensated CHF +/ Low normal

More information

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty

More information

Congestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption

Congestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Congestive Heart Failure Patient Profile Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Chief Complaint - SOB - When asked: Increasing difficulty

More information

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF CLASSIFICATION OF HEART FAILURE Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF DISCLOSURES: NONE CLASSIFICATION C OF HEART FAILURE NYHA I IV New paradigm Stage A: Pts at high risk of developing

More information

The right heart: the Cinderella of heart failure

The right heart: the Cinderella of heart failure The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart

More information

Mechanical Support in the Failing Fontan-Kreutzer

Mechanical Support in the Failing Fontan-Kreutzer Mechanical Support in the Failing Fontan-Kreutzer Stephanie Fuller MD, MS Thomas L. Spray Endowed Chair in Congenital Heart Surgery Associate Professor, The Perelman School of Medicine at the University

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACHD. See Adult congenital heart disease (ACHD) Adult congenital heart disease (ACHD), 503 512 across life span prevalence of, 504 506

More information

CLINICAL PRACTICE GUIDELINE

CLINICAL PRACTICE GUIDELINE CLINICAL PRACTICE GUIDELINE Procedure: Congestive Heart Failure Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014

More information

Heart Failure. Dr. William Vosik. January, 2012

Heart Failure. Dr. William Vosik. January, 2012 Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ID NUMBER: FORM NAME: H F A DATE: 10/01/2015 VERSION: D CONTACT YEAR NUMBER: FORM SEQUENCE NUMBER: General Instructions: The Heart Failure Hospital Record

More information

Heart Failure with Reduced EF. Dino Recchia, MD, FACC, FHFSA

Heart Failure with Reduced EF. Dino Recchia, MD, FACC, FHFSA Heart Failure with Reduced EF Dino Recchia, MD, FACC, FHFSA Heart Failure HF is the end phenotype of almost all CV disorders Complex clinical syndrome resulting from any structural or functional impairment

More information

Heart Failure. Symptoms and Treatments. FloridaHospital.com

Heart Failure. Symptoms and Treatments. FloridaHospital.com Heart Failure Symptoms and Treatments FloridaHospital.com Understanding Heart Failure According to the American Heart Association, one in five people over age 40 will develop heart failure. Right now,

More information

Akash Ghai MD, FACC February 27, No Disclosures

Akash Ghai MD, FACC February 27, No Disclosures Akash Ghai MD, FACC February 27, 2015 No Disclosures Epidemiology Lifetime risk is > 20% for American s older than 40 years old. > 650,000 new cases diagnosed each year. Incidence increases with age: 2%

More information

Predicting Outcomes in LVAD Recipients

Predicting Outcomes in LVAD Recipients Predicting Outcomes in LVAD Recipients Sean P. Pinney, MD Director, Advanced Heart Failure & Cardiac Transplantation Professor of Medicine, Cardiology Icahn School of Medicine at Mount Sinai New York,

More information

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD

A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD SK Singh MD MSc, DK Pujara MBBS, J Anand MD, WE Cohn MD, OH Frazier MD, HR Mallidi MD Division of Transplant & Assist

More information

Pathophysiology: Left To Right Shunts

Pathophysiology: Left To Right Shunts Pathophysiology: Left To Right Shunts Daphne T. Hsu, MD dh17@columbia.edu Learning Objectives Learn the relationships between pressure, blood flow, and resistance Review the transition from fetal to mature

More information

Heart Failure Symposium: Case Presentation (The crash and burn and the smoldering patient)

Heart Failure Symposium: Case Presentation (The crash and burn and the smoldering patient) Heart Failure Symposium: (The crash and burn and the smoldering patient) Patrick C. Magnus, MBBS, MPH Clinical Fellow Section of Cardiology Dartmouth Hitchcock Medical Center (Case 1) 66 year old man,

More information

Ontario s Referral and Listing Criteria for Adult Heart Transplantation

Ontario s Referral and Listing Criteria for Adult Heart Transplantation Ontario s Referral and Listing Criteria for Adult Heart Transplantation Version 3.0 Trillium Gift of Life Network Adult Heart Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The

More information

Atrioventricular Valve Endocardiosis Basics

Atrioventricular Valve Endocardiosis Basics Atrioventricular Valve Endocardiosis Basics OVERVIEW Atrioventricular valve refers to the heart valves between the top chamber (known as the atrium ) and the bottom chamber (known as the ventricle ) of

More information

Ventricular Assist Devices

Ventricular Assist Devices Page 1 By Tonya Elliott, RN, MSN Background, Indications for VADs Mechanical circulatory support has become an acceptable therapy for end stage heart failure (HF) in maximally medically treated patients

More information

Outline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease

Outline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease Special Considerations for Special Populations: Congenital Heart Disease Valerie Bosco, FNP, EdD Alison Knauth Meadows, MD, PhD University of California San Francisco Adult Congenital Heart Program Outline

More information

Medical Management of Acutely Decompensated Heart Failure. William T. Abraham, MD Director, Division of Cardiovascular Medicine

Medical Management of Acutely Decompensated Heart Failure. William T. Abraham, MD Director, Division of Cardiovascular Medicine Medical Management of Acutely Decompensated Heart Failure William T. Abraham, MD Director, Division of Cardiovascular Medicine Orlando, Florida October 7-9, 2011 Goals of Acute Heart Failure Therapy Alleviate

More information

Pathophysiology: Left To Right Shunts

Pathophysiology: Left To Right Shunts Pathophysiology: Left To Right Shunts Daphne T. Hsu, MD dh17@columbia.edu Learning Objectives Learn the relationships between pressure, blood flow, and resistance Review the transition from fetal to mature

More information

Acute heart failure, beyond conventional treatment: persisting low output

Acute heart failure, beyond conventional treatment: persisting low output Acute heart failure, beyond conventional treatment: persisting low output Alexandre Mebazaa, FESC Hôpital Lariboisière, Université Paris 7 U942 Inserm Conflict of Interest Lecture fee: Orion No other conflicts

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

More information

Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40%

Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40% Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes Severe Hypertension *Prior to making a referral, call office or Doc Halo, to speak with a Cardiologist or APP to discuss patient and possible treatment options. Please only contact the patient's cardiologist.

More information

WHEN TO REFER FOR ADVANCED HEART FAILURE THERAPIES

WHEN TO REFER FOR ADVANCED HEART FAILURE THERAPIES WHEN TO REFER FOR ADVANCED HEART FAILURE THERAPIES Mrudula R Munagala, M.D., FACC CO- Director Heart Failure & Circulatory Support Program OklahomaHeart.com Heart Failure Prevalence Heart Failure affects

More information

Cardiorenal and Renocardiac Syndrome

Cardiorenal and Renocardiac Syndrome And Renocardiac Syndrome A Vicious Cycle Cardiorenal and Renocardiac Syndrome Type 1 (acute) Acute HF results in acute kidney injury Type 2 Chronic cardiac dysfunction (eg, chronic HF) causes progressive

More information

Hemodynamic Monitoring and Circulatory Assist Devices

Hemodynamic Monitoring and Circulatory Assist Devices Hemodynamic Monitoring and Circulatory Assist Devices Speaker: Jana Ogden Learning Unit 2: Hemodynamic Monitoring and Circulatory Assist Devices Hemodynamic monitoring refers to the measurement of pressure,

More information

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA

What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA What are the indications for Tricuspid valve repair during LVAD Implant RANJIT JOHN, MD UNIVERSITY OF MINNESOTA Contraindications for LVAD Lack of social support system Nonreversible end organ failure

More information

Difficult Data Definitions and Scenario s

Difficult Data Definitions and Scenario s Difficult Data Definitions and Scenario s Presenter Disclosure Information Cornelia Anderson BSN, RN To following relationships exist related to this presentation: No Disclosures Objectives Discuss key

More information

Cardiac Disease in Fatty Acid Oxidation Disorders

Cardiac Disease in Fatty Acid Oxidation Disorders Cardiac Disease in Fatty Acid Oxidation Disorders Kathryn Chatfield, MD, PhD Assistant Professor of Pediatrics Division of Cardiology University of Colorado School of Medicine Children s Hospital Colorado

More information

EACTS Adult Cardiac Database

EACTS Adult Cardiac Database EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list

More information

Congestive Heart Failure

Congestive Heart Failure Sheri Saluga Anatomy and Physiology II March 4, 2010 Congestive Heart Failure Scenario George is in congestive heart failure. Because of his condition, his ankles and feet appear to be swollen and he has

More information

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI Percutaneous Mechanical Circulatory Support for Cardiogenic Shock 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI The Need for Circulatory Support Basic Pathophysiologic Problems:

More information

4 Has this patient been transplanted No

4 Has this patient been transplanted No Form 1RL: Relisting Print this Form t Started 1 Date of Relisting Height and Weight 2 Height Centimeters Inches Calculated BSA: n/a BMI: n/a 3 Weight Kilograms Pounds 4 Has this patient been transplanted

More information

Summary/Key Points Introduction

Summary/Key Points Introduction Summary/Key Points Introduction Scope of Heart Failure (HF) o 6.5 million Americans 20 years of age have HF o 960,000 new cases of HF diagnosed annually o 5-year survival rate for HF is ~50% Classification

More information

Heart Failure (HF) Treatment

Heart Failure (HF) Treatment Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and

More information

Cardiogenic Shock in Acute MI

Cardiogenic Shock in Acute MI Cardiogenic Shock in Acute MI Mark Sheldon, MD UNMH Interventional Cardiology Objectives Overview Treatment Definition Shock profiles Causes Medical Mechanical Illustrative case Questions? Revascularization

More information

Management of Acute Shock and Right Ventricular Failure

Management of Acute Shock and Right Ventricular Failure Management of Acute Shock and Right Ventricular Failure Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic NONE Disclosures CARDIOGENIC SHOCK

More information

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Lucia Jewbali cardiologist-intensivist 14 beds/8 ICU beds Acute coronary syndromes Heart failure/ Cardiogenic shock Post cardiotomy Heart

More information

Post-Cardiac Surgery Evaluation

Post-Cardiac Surgery Evaluation Post-Cardiac Surgery Evaluation 20th Annual Heart Conference October 15, 2016 Gary A Mayman PROFESSOR PEDIATRICS UNIVERSITY OF NEVADA Look Touch Listen Temperature, pulse, respiratory rate, & blood pressure

More information

Cardiogenic Shock Protocol

Cardiogenic Shock Protocol Cardiogenic Shock Protocol Impella Devices Best Practices in AMI Cardiogenic Shock Identify 1-3 SBP < 90 mmhg or on inotropes /pressors Cold, clammy, tachycardia Lactate elevated > 2 mmoi /L Stabilize

More information

End of Life Care in IJN Our journey. Dato Dr. David Chew Soon Ping Consultant Cardiologist National Heart Institute Malaysia

End of Life Care in IJN Our journey. Dato Dr. David Chew Soon Ping Consultant Cardiologist National Heart Institute Malaysia End of Life Care in IJN Our journey Dato Dr. David Chew Soon Ping Consultant Cardiologist National Heart Institute Malaysia End of Life Dying is final part of everyone journey in life Deaths used to occur

More information

From Recovery to Transplant: One Patient's Journey

From Recovery to Transplant: One Patient's Journey From Recovery to Transplant: One Patient's Journey Tonya Elliott, RN, MSN Assist Device and Thoracic Transplant Coordinator Inova Transplant Center at Inova Fairfax Hospital Falls Church, VA Introduction

More information

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Pinpoint & properly assign the appropriate heart failure codes Left- vs. Right-sided Left ventricular failure (LVF) may

More information

Patient Resources: Arrhythmias and Congenital Heart Disease

Patient Resources: Arrhythmias and Congenital Heart Disease Patient Resources: Arrhythmias and Congenital Heart Disease Overview Arrhythmias (abnormal heart rhythms) can develop in patients with congenital heart disease (CHD) due to thickening/weakening of their

More information

Tricuspid valve surgery in patients with a systemic right ventricle

Tricuspid valve surgery in patients with a systemic right ventricle Tricuspid valve surgery in patients with a systemic right ventricle Roderick Scherptong, Hubert Vliegen, Michiel Winter, Barbara Mulder, Ernst van der Wall, Dave Koolbergen, Mark Hazekamp Eduard Holman,

More information

State-of-the-Art Management of Chronic Systolic Heart Failure

State-of-the-Art Management of Chronic Systolic Heart Failure State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures

More information

Assessment and Diagnosis of Heart Failure

Assessment and Diagnosis of Heart Failure Assessment and Diagnosis of Heart Failure Heart failure (HF) is a complex clinical syndrome resulting from any structural or functional impairment of ventricular filling or ejection of blood and is characterized

More information